How should tetralogy of Fallot with absent pulmonary valve be managed in a newborn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Tetralogy of Fallot with Absent Pulmonary Valve in Newborns

Newborns with TOF-absent pulmonary valve presenting with severe respiratory distress require urgent surgical intervention with complete repair including VSD closure, reduction pulmonary arterioplasty, and establishment of RV-PA continuity, preferably using a valveless transannular patch approach rather than a valved conduit.

Initial Stabilization and Diagnosis

Immediate Respiratory Management

Newborns with TOF-absent pulmonary valve typically present with severe respiratory compromise due to aneurysmal pulmonary arteries compressing the tracheobronchial tree. The majority (85%) require preoperative ventilatory assistance 1. Critical stabilization measures include:

  • Prone positioning to relieve airway compression 2
  • Mechanical ventilation as needed
  • Consider emergency sternotomy if ventilatory status cannot be stabilized 2

Diagnostic Workup

  • Comprehensive echocardiography to assess anatomy, ventricular function, and degree of pulmonary regurgitation
  • Genetic testing for 22q11.2 deletion (present in 35% of cases) and other chromosomal abnormalities (46% overall) 3
  • Evaluate for ventricular dysfunction: Right ventricular dysfunction independently predicts overall mortality (OR 7.9), while left ventricular dysfunction predicts fetal demise (OR 7.4) 3
  • CT scan to assess degree of tracheobronchial compression

Surgical Timing and Approach

Primary Complete Repair (Preferred Strategy)

Primary repair in the neonatal period or early infancy is the preferred approach, with excellent outcomes reported when performed early 1. The median age at surgery in successful series is 15 days (range 2-1,154 days) 1.

Surgical Technique Components

The operation must include:

  1. VSD closure with patch
  2. Reduction pulmonary arterioplasty - critical to reduce aneurysmal pulmonary arteries and relieve airway compression 1, 4
  3. Mobilization and translocation of pulmonary arteries anterior to the aorta and away from the tracheobronchial tree 4
  4. Establishment of RV-PA continuity

RV-PA Continuity: Valveless vs. Valved Approach

A valveless transannular patch/hood is preferred over valved homograft based on contemporary evidence 1. Here's why:

  • Valveless connections have lower reoperation rates when combined with catheter-based interventions for residual stenosis
  • Homografts require reoperation for conduit stenosis or degeneration
  • All patients will have free pulmonary regurgitation regardless of approach, but demonstrate good biventricular function with valveless repair 1
  • 89% overall survival achieved with valveless approach in neonates/infants 1

Important caveat: Assess coronary anatomy preoperatively - if an anomalous anterior descending coronary crosses the RVOT, an extracardiac conduit may be necessary 5.

Alternative Staging Strategy (Historical, Less Preferred)

A two-stage approach with initial pulmonary artery banding ± Blalock-Taussig shunt followed by delayed complete repair can be considered for extremely unstable neonates who cannot be stabilized for primary repair 6. However, this is rarely necessary with modern techniques and carries the burden of multiple operations.

Outcomes and Prognosis

Early Mortality

  • In-hospital mortality: 25% in registry data 7
  • Most deaths occur in the first 13 months postoperatively 1
  • Contemporary single-center series report 89% survival with optimized technique 1

Long-term Survival

Once patients survive to hospital discharge, long-term outcomes are excellent:

  • 25-year transplant-free survival: 92% - similar to simple TOF with non-valve sparing procedures 7
  • No deaths after 13 months in recent series 1
  • Respiratory symptoms disappear or significantly improve in all survivors 4

Postoperative Management and Follow-up

Expected Postoperative Issues

  • Free pulmonary regurgitation - universal and well-tolerated
  • Potential need for catheter-based intervention (balloon angioplasty/stenting) for residual branch PA stenosis - occurs in ~13% 1
  • Rare need for reoperation (~17%) for conversion to valveless connection or repair of stenosis 1

Surveillance

  • Regular follow-up with congenital heart disease specialist
  • Serial echocardiography to assess biventricular function
  • Monitor for arrhythmias (though less common than in standard TOF)

Critical Pitfalls to Avoid

  1. Delaying surgery in symptomatic neonates - respiratory distress indicates need for urgent intervention
  2. Using valved homografts routinely - increases reoperation burden without clear benefit
  3. Failing to perform adequate reduction arterioplasty - inadequate reduction leaves persistent airway compression
  4. Not translocating pulmonary arteries anteriorly - leaves them in contact with tracheobronchial tree 4
  5. Missing anomalous coronary anatomy - can lead to coronary injury during RVOT reconstruction

The key to success is early primary complete repair with aggressive reduction arterioplasty and PA translocation, using a valveless RV-PA connection in experienced congenital cardiac surgical centers 1, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.